Literature DB >> 12042048

Design and operation of a current good manufacturing practices cell-engineering laboratory.

S R Burger1.   

Abstract

Medical centers and biotechnology companies active in cellular and gene therapy increasingly are working to design and build clinical laboratories capable of performing cellular engineering and vector production using current good manufacturing practices (cGMPs). Because cell engineering is a rapidly changing field, and definitions for cell engineering cGMPs are still being established, a cGMP cell-engineering laboratory most often should be designed with a broad range of potential applications in mind. While the laboratory facility is the most tangible aspect of cGMP, it represents only part of a larger process, which it must be designed and built to support.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12042048     DOI: 10.1080/146532400539116

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  6 in total

Review 1.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  Essential requirements for setting up a stem cell processing laboratory.

Authors:  T Leemhuis; D Padley; C Keever-Taylor; D Niederwieser; T Teshima; F Lanza; C Chabannon; P Szabolcs; A Bazarbachi; M B C Koh
Journal:  Bone Marrow Transplant       Date:  2014-06-16       Impact factor: 5.483

3.  Establishing a stem cell culture laboratory for clinical trials.

Authors:  Elíseo Joji Sekiya; Andresa Forte; Telma Ingrid Borges de Bellis Kühn; Felipe Janz; Sérgio Paulo Bydlowski; Adelson Alves
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 4.  Drug-loaded erythrocytes: on the road toward marketing approval.

Authors:  Vanessa Bourgeaux; José M Lanao; Bridget E Bax; Yann Godfrin
Journal:  Drug Des Devel Ther       Date:  2016-02-11       Impact factor: 4.162

Review 5.  Perspectives for Clinical Translation of Adipose Stromal/Stem Cells.

Authors:  Mimmi Patrikoski; Bettina Mannerström; Susanna Miettinen
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

Review 6.  Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells.

Authors:  Nadine E Rekittke; Meidjie Ang; Divya Rawat; Rahul Khatri; Thomas Linn
Journal:  Stem Cells Int       Date:  2016-03-07       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.